Averill Master Fund, Ltd., Director, 10% Owner at Benitec Biopharma Inc. (BNTC), bought 78,226 shares at $10.22 ($787K) on 2024-11-20, disclosed to the SEC on 2024-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.73 | 1,570 | $15K | 1.9% |
| 2 | $9.73 | 12,430 | $121K | 15.4% |
| 3 | $9.73 | 12,430 | $121K | 15.4% |
| 4 | $10.22 | 3,076 | $31K | 4.0% |
| 5 | $10.22 | 24,360 | $249K | 31.7% |
| 6 | $10.22 | 24,360 |
| $249K |
| 31.7% |
| Total | $10.05 avg | 78,226 | $787K | 100% |